|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Primavesi F, Stattner S, Jager T, Gobel G,
Presl J, Tomanova K, Buchner S, Maglione M, Resch T, Hutter J, et
al: Progressive oncological surgery is associated with increased
curative resection rates and improved survival in metastatic
colorectal cancer. Cancers (Basel). 11:E2182019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kopetz S, Chang GJ, Overman MJ, Eng C,
Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM and
McWilliams RR: Improved survival in metastatic colorectal cancer is
associated with adoption of hepatic resection and improved
chemotherapy. J Clin Oncol. 27:3677–3683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang Z, Li X, Liu S, Li C, Wang X and
Xing J: MiR-141-3p inhibits cell proliferation, migration and
invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys
Res Commun. 514:699–705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Zhang X, Zhang Q and Lin R: miR-182
contributes to cell proliferation, invasion and tumor growth in
colorectal cancer by targeting DAB2IP. Int J Biochem Cell Biol.
111:27–36. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou GH, Lu YY, Xie JL, Gao ZK, Wu XB, Yao
WS and Gu WG: Overexpression of miR-758 inhibited proliferation,
migration, invasion, and promoted apoptosis of non-small cell lung
cancer cells by negatively regulating HMGB. Biosci Rep.
39:BSR201808552019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng X, Zhao Y, Wang J, Gao Z, Geng Q and
Liu X: Regulatory roles of miRNA-758 and matrix extracellular
phosphoglycoprotein in cervical cancer. Exp Ther Med. 14:2789–2794.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elso C, Lu X, Weisner PA, Thompson HL,
Skinner A, Carver E and Stubbs L: A reciprocal translocation
dissects roles of Pax6 alternative promoters and upstream
regulatory elements in the development of pancreas, brain, and eye.
Genesis. 51:630–646. 2013.PubMed/NCBI
|
|
10
|
Li L, Li B, Zhang H, Bai S, Wang Y, Zhao B
and Jonas JB: Lentiviral vector-mediated PAX6 overexpression
promotes growth and inhibits apoptosis of human retinoblastoma
cells. Invest Ophthalmol Vis Sci. 52:8393–8400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zong X, Yang H, Yu Y, Zou D, Ling Z, He X
and Meng X: Possible role of Pax-6 in promoting breast cancer cell
proliferation and tumorigenesis. BMB Rep. 44:595–600. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Needhamsen M, White RB, Giles KM, Dunlop
SA and Thomas MG: Regulation of Human PAX6 Expression by miR-7.
Evol Bioinform Online. 10:107–113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slattery ML, Mullany LE, Sakoda LC, Wolff
RK, Stevens JR, Samowitz WS and Herrick JS: The PI3K/AKT signaling
pathway: Associations of miRNAs with dysregulated gene expression
in colorectal cancer. Mol Carcinog. 57:243–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song Y, Zhao Y, Ding X and Wang X:
microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit
colorectal cancer progression by directly targeting IGF-1R. Am J
Cancer Res. 8:435–449. 2018.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Xu M, Lu P and Zhou F:
microRNA-769 is downregulated in colorectal cancer and inhibits
cancer progression by directly targeting cyclin-dependent kinase 1.
Onco Targets Ther. 11:9013–9025. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu X, Li Y, Kong D, Hu L, Liu D and Wu J:
Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p
to facilitate the malignancy of ovarian cancer. J Cell Physiol.
234:10800–10808. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Zhang Z, Pan L and Zhou Y:
Identification of miR-758-3p as potential modulator of CBX5
expression in gastric cancer. Technol Cancer Res Treat.
17:15330338188160612018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu X, Chen B, Shi H, Zhou J, Zhou F, Cao J
and Sun X: miR-758-3p suppresses human bladder cancer cell
proliferation, migration and invasion by targeting NOTCH2. Exp Ther
Med. 17:4273–4278. 2019.PubMed/NCBI
|
|
20
|
Jiang D, Cho W, Li Z, Xu X, Qu Y, Jiang Z,
Guo L and Xu G: MiR-758-3p suppresses proliferation, migration and
invasion of hepatocellular carcinoma cells via targeting MDM2 and
mTOR. Biomed Pharmacother. 96:535–544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu J, Jiang J, Hui X, Wang W, Fang D and
Ding L: MiR-758-5p suppresses glioblastoma proliferation, migration
and invasion by targeting ZBTB20. Cell Physiol Biochem.
48:2074–2083. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang S and Jiang M: The long non-coding
RNA-DANCR exerts oncogenic functions in non-small cell lung cancer
via miR-758-3p. Biomed Pharmacother. 103:94–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Zheng J, Lin J, Chen J, Yu Z,
Chen C and Liu T: miR-758 mediates oxLDL-dependent vascular
endothelial cell damage by suppressing the succinate receptor
SUCNR1. Gene. 663:1–8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li BR, Xia LQ, Liu J, Liao LL, Zhang Y,
Deng M, Zhong HJ, Feng TT, He PP and Ouyang XP: miR-758-5p
regulates cholesterol uptake via targeting the CD36 3′UTR. Biochem
Biophys Res Commun. 494:384–389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Yang L, Shuai T, Piao T and Wang R:
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1
and PAX6 expression. Biomed Pharmacother. 82:247–255. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zou Q, Yi W, Huang J, Fu F, Chen G and
Zhong D: MicroRNA-375 targets PAX6 and inhibits the viability,
migration and invasion of human breast cancer MCF-7 cells. Exp Ther
Med. 14:1198–1204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Li Y, Liu Y, Xie P, Li F and Li G:
PAX6, a novel target of microRNA-7, promotes cellular proliferation
and invasion in human colorectal cancer cells. Dig Dis Sci.
59:598–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng Q, Cao H, Chen Z, Ma Z, Wan X, Peng
R and Jiang B: PAX6, a novel target of miR-335, inhibits cell
proliferation and invasion in glioma cells. Mol Med Rep.
10:399–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan F, Liu J, Pang H, Tian Y, Yuan K, Li
Y, Wang J, Bian S, Zheng Y, Dong D, et al: MicroRNA-365 suppressed
cell proliferation and migration via targeting PAX6 in
glioblastoma. Am J Transl Res. 11:361–369. 2019.PubMed/NCBI
|
|
30
|
Meng Y, Zou Q, Liu T, Cai X, Huang Y and
Pan J: microRNA-335 inhibits proliferation, cell-cycle progression,
colony formation, and invasion via targeting PAX6 in breast cancer
cells. Mol Med Rep. 11:379–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1186. 2013. View Article : Google Scholar : PubMed/NCBI
|
